Table 1 Clinicopathological characteristics of patients with high-risk stage II and stage III rectal cancer after TME surgery
Mean (SD), median (min–max) | |
|---|---|
Age | 54.6 (12.8), 56.0 (18.0–85.0) |
Gender (N, %) | |
Male | 244 (61.0%) |
Female | 156 (39.0%) |
T stage (N, %) | |
T1–2 | 21 (5.25%) |
T3–4 | 379 (94.75%) |
N stage (N, %) | |
N0 | 182 (45.5%) |
N1 | 140 (35.0%) |
N2 | 78 (19.5%) |
PLNR | 0.145 (0.23), 0.02 (0.00–1.00) |
< 0.145 | 286 (71.50%) |
≥ 0.145 | 114 (28.50%) |
Differentiation (N, %) | |
Moderate to high | 350 (87.5%) |
Poor | 50 (12.5%) |
CA199 | 26.97 (69.9), 11.1 (0.00–700) |
Normal | 352 (89.34%) |
Elevated | 42 (10.66%) |
CEA | 6.16 (14.5), 1.82 (0.00–101.5) |
Normal | 312 (78.00%) |
Elevated | 88 (22.00%) |
PNI | 49.1 (5.51), 49.00 (27.0–68.2) |
PNI tertile 1 | 132 (33.00%) |
PNI tertile 2 | 134 (33.50%) |
PNI tertile 3 | 134 (33.50%) |
NLR | 3.21 (3.19), 2.29 (0.72–33.0) |
NLR tertile 1 | 133 (33.25%) |
NLR tertile 2 | 133 (33.25%) |
NLR tertile 3 | 134 (33.50%) |
Number of ACT cycle | 5.43 (3.17), 6.00 (0.00–12.0) |
0 | 36 (9.00%) |
1–6 | 228 (57.00%) |
7–12 | 136 (34.00%) |
CCRT (N, %) | |
Without | 147 (36.8%) |
With | 253 (63.3%) |